|
Market Closed -
Nasdaq
01:00:00 11/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 253.25 USD | -0.64% |
|
+1.74% | +43.90% |
| 11-09 | UCB And Biogen Announce Clinical Profile Data For Dapirolizumab Pegol In Systemic Lupus Erythematosus | CI |
| 10-29 | Biogen Presents New Data Across Alzheimer?S Disease Portfolio At CTAD 2026 | CI |
| Market Cap | 37.44B 33.57B 30.94B 28.1B 53.18B 3,510B 54.66B 370B 148B 1,880B 140B 138B 5,945B | P/E 2026 * |
51.1x | P/E 2027 * | 22.8x |
|---|---|---|---|---|---|
| Enterprise Value | 43.07B 38.63B 35.6B 32.33B 61.18B 4,038B 62.89B 426B 170B 2,164B 162B 158B 6,839B | EV / Sales 2026 * |
4.07x | EV / Sales 2027 * | 3.76x |
| Free-Float |
85.81% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| BIIB | Delayed | |
CBOE
| BIIB | Real-time | |
|
Boerse Muenchen
| IDP | Real-time | |
|
Tradegate
| IDP | Real-time | |
|
Börse Stuttgart
| IDP | Delayed | |
|
Xetra
| IDP | Delayed | |
|
Mexican S.E.
| BIIB * | End-of-day quote | |
|
Borsa Italiana
| 1BIIB | End-of-day quote | |
|
Kazakhstan S.E.
| BIIB_KZ | End-of-day quote | |
|
Deutsche Boerse AG
| IDP | Delayed | |
|
Swiss Exchange
| BIIB | Delayed | |
|
Wiener Boerse
| BIIB | End-of-day quote | |
|
Santiago S.E.
| BIIB | End-of-day quote | |
|
Santiago S.E.
| BIIBCL | End-of-day quote | |
|
Swiss Exchange
| BIIB | Delayed |
Last Transcript: Biogen Inc.
| 1 day | -0.64% | ||
| 1 week | +1.74% | ||
| Current month | -0.15% | ||
| 1 month | +12.20% | ||
| 3 months | +22.27% | ||
| 6 months | +30.91% | ||
| Current year | +43.90% |
| 1 week | 240 |  | 261 |
| 1 month | 226.71 | | 261 |
| Current year | 160.36 | | 261 |
| 1 year | 158.05 | | 261 |
| 3 years | 110.04 | | 268.3 |
| 5 years | 110.04 | | 319.76 |
| 10 years | 110.04 | | 468.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 14/11/2022 | |
Robin Kramer
DFI | Director of Finance/CFO | 60 | 01/03/2025 |
Daniel Quirk
CTO | Chief Tech/Sci/R&D Officer | - | 28/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Eric Rowinsky
BRD | Director/Board Member | 69 | 23/03/2010 |
Stephen Sherwin
BRD | Director/Board Member | 77 | 01/01/2010 |
William Hawkins
BRD | Director/Board Member | 72 | 19/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/10/26 | Exercice | Chief Technology Officer | 1,735 | 0.0012% | ||
| 02/10/26 | Exercice | Controller/Auditor | 62 | 0.0000% | ||
| 01/09/26 | Free | General Counsel | 7,405 | 0.0050% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.64% | +1.74% | +62.07% | +12.66% | 37.67B | |
| +1.44% | +1.63% | +48.17% | +139.63% | 1,258B | |
| -0.47% | +5.49% | +49.03% | +90.68% | 679B | |
| +0.20% | +2.76% | +34.37% | +112.06% | 518B | |
| +0.17% | +2.76% | +44.07% | +69.71% | 390B | |
| -0.48% | +2.34% | +70.66% | +46.02% | 367B | |
| +0.76% | +2.27% | +31.59% | +60.36% | 307B | |
| -1.29% | +0.90% | +5.77% | +37.60% | 293B | |
| 0.00% | +0.86% | +43.74% | +74.04% | 252B | |
| +0.92% | +2.03% | +44.62% | +125.07% | 210B | |
| Average | -0.09% | +1.18% | +43.41% | +76.78% | 431B | |
| Weighted average by Cap. | -0.10% | +1.19% | +43.82% | +96.10% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.57B 9.48B 8.74B 7.94B 15.02B 991B 15.44B 105B 41.69B 531B 39.69B 38.84B 1,679B | 10.78B 9.66B 8.91B 8.09B 15.31B 1,010B 15.74B 107B 42.49B 541B 40.44B 39.59B 1,711B |
| Net income | 788M 707M 651M 591M 1.12B 73.88B 1.15B 7.8B 3.11B 39.58B 2.96B 2.89B 125B | 1.79B 1.6B 1.48B 1.34B 2.54B 168B 2.61B 17.68B 7.04B 89.74B 6.7B 6.56B 284B |
| Net Debt | 5.63B 5.05B 4.66B 4.23B 8B 528B 8.23B 55.76B 22.22B 283B 21.15B 20.7B 895B | 3.08B 2.76B 2.55B 2.31B 4.38B 289B 4.5B 30.49B 12.15B 155B 11.56B 11.32B 489B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/11/26 | $253.25 | -0.64% | 735,003 |
| 09/11/26 | $254.87 | +2.63% | 1,143,244 |
| 06/11/26 | $248.35 | +1.81% | 1,002,119 |
| 05/11/26 | $243.93 | -4.14% | 1,221,066 |
| 04/11/26 | $254.46 | +2.22% | 1,348,003 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- BIIB Stock
Select your edition
All financial news and data tailored to specific country editions
